Latest posts

• 

  May 1, 2017 • 316

  New drug combination therapy could treat the world’s worst infectious diseases

    Eric Brown, a scientist at the Michael G. DeGroote Institute for Infectious Disease Research (IIDR) at McMaster...

  Business Focus, Clinical Trials, Drug Development, Feature, Feature Slider, Feature-Home, Featured-Slides-Home, Oncology, Science Focus Read More

• 

  November 13, 2018 • 32

  MaRS Innovation continues to tighten the Canadian Innovation-based relationship with South-Korea

  The world is getting that much smaller as countries expand their reach across the globe, fueling collaboration to stem...

  Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  November 10, 2018 • 47

  Tackling the Talent Gap in the Cell and Gene Therapy Industry

  For those of us who have been following and working in the cell and gene therapy (CGT) field for a significant number...

  Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  November 8, 2018 • 274

  New class of antiviral drugs may alleviate influenza symtoms

  As winter draws near, the risk of catching influenza heightens. To help alleviate symptoms, an infectious disease...

  Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  October 25, 2018 • 188

  Canadian life sciences leaders come together to deliberate recommendations with the Federal government

  Three exemplary organizations in Canada are hosting an event to advance the Canadian health and biosciences sector to...

  Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  October 23, 2018 • 193

  Experimental treatment from the Ottawa Hospital eradicates acute myeloid leukemia

  An innovative promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) has come out of...

  Feature Read More

• 

  October 22, 2018 • 214

  The Government of Canada and CIHR invest in a Lyme disease research network

  The Canadian Institutes of Health Research (CIHR) and the Government of Canada invest $4 million in a new...

  Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  October 4, 2018 • 140

  Therapure approves manufacturing of Arikayce at its Mississauga location

  Therapure Biomanufacturing, an integrated contract development and manufacturing organization (CDMO) and a division of...

  Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  October 3, 2018 • 158

  Understanding silver: Could this be the next “resistant” antimicrobial?

  Silver has long been used as an antimicrobial to kill harmful bacteria. With people using the knowledge of its...

  Feature Slider, Feature-Home, Featured-Slides-Home Read More

• Recent Posts